电阻抗断层成像(EPT)鉴别乳腺良恶性病变的诊断价值:与标准动态增强MRI的比较
本回顾性研究纳入116例患者共141个乳腺病变(良性50个、恶性91个),于2014年1月至2017年1月行3-T MRI(含3D TSE序列和标准DCE-MRI)。恶性病变的平均电导率和SER均显著高于良性病变,但IER无显著差异;平均电导率AUC为0.71,SER的AUC为0.80,两者无显著差异。EPT的平均电导率在乳腺良恶性病变间存在显著差异,其诊断能力与DCE-MRI的SER无显著差异。
要点
- 恶性乳腺病变的平均电导率高于良性病变(1.14 ± 1.36 vs 0.14 ± 1.77 S/m,p < 0.0001)。
- EPT平均电导率鉴别乳腺良恶性病变的AUC为0.71,与DCE-MRI的SER(AUC 0.80)无显著差异(p = 0.15)。
- EPT有助于鉴别乳腺良恶性病变,其诊断能力与DCE-MRI无显著差异。
核心结论
- EPT的平均电导率在乳腺良恶性病变间存在显著差异,其诊断能力与DCE-MRI的SER无显著差异。
研究设计与样本
- 经机构审查委员会批准的回顾性研究,纳入2014年1月至2017年1月连续的116例患者共141个乳腺病变(良性50个、恶性91个),均行3-T MRI(含3D TSE序列和标准DCE-MRI)。
关键影像表现/征象
- 利用减影DCE-MR图像半自动分割病灶,并将其配准至3D TSE的相位图像。
- 通过基于相位的重建获得病灶的平均电导率。
- 从DCE-MRI根据信号强度计算初始增强率(IER)和信号增强比(SER)。
诊断标准与关键数值
- 恶性病变平均电导率1.14 ± 1.36 S/m vs 良性病变0.14 ± 1.77 S/m,p < 0.0001。
- 恶性病变SER 1.04 ± 0.25 vs 良性病变0.77 ± 0.28,p < 0.0001。
- IER在良恶性病变间无显著差异(p = 0.06)。
- 平均电导率鉴别良恶性病变的AUC为0.71,SER的AUC为0.80,两者无显著差异(p = 0.15)。
临床应用与阅片要点
- EPT的平均电导率可作为鉴别乳腺良恶性病变的辅助参数,其诊断能力与DCE-MRI的SER无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the diagnostic utility of electric properties tomography (EPT) in differentiating benign from malignant breast lesions in comparison with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
METHODS: In this institutional review board-approved retrospective study, 116 consecutive patients with 141 breast lesions (50 benign and 91 malignant) underwent 3-T MRI, including 3D turbo-spin echo (TSE) sequence and standard DCE-MRI scans between January 2014 and January 2017. The lesions were segmented semi-automatically using subtraction DCE-MR images, and they were registered to the phase images from 3D TSE. The mean conductivity of the lesion was obtained from phase-based reconstruction of lesions. From the DCE-MRI, initial enhancement rate (IER) and signal enhancement ratio (SER) were calculated from signal intensity (SI) as follows: IER = (SIearly - SIpre)/SIpre, SER = (SIearly - SIpre)/(SIdelayed - SIpre). The parameters from EPT and the DCE-MRI were compared between benign and malignant lesions.
RESULTS: There was significant difference in mean conductivity (0.14 ± 1.77 vs 1.14 ± 1.36 S/m, p < 0.0001) and SER (0.77 ± 0.28 vs 1.04 ± 0.25, p < 0.0001) between benign and malignant lesions, but not in IER (p = 0.06). Receiver operating curve (ROC) analysis revealed that the area under the curve (AUC) of the mean conductivity and SER was 0.71 and 0.80, respectively, without significant difference (p = 0.15).
CONCLUSIONS: The mean conductivity of EPT was significantly different between benign and malignant breast lesions as well as kinetic parameter or SER from DCE-MRI.
KEY POINTS: • The conductivity of malignant lesions was higher than that of benign lesions. • EPT helps differentiatie benign from malignant lesions. • Diagnostic ability of EPT was not significantly different from that of DCE-MRI.
引用
- Mori N, Tsuchiya K, Sheth D, et al. Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI. Eur Radiol. 2018. PMID: 30255252. doi:10.1007/s00330-018-5708-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。